171 related articles for article (PubMed ID: 6485015)
1. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse.
White RD; Norton R; Bus JS
Toxicol Lett; 1984 Oct; 23(1):25-32. PubMed ID: 6485015
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
Manning BW; Franklin MR; Galinsky RE
Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
4. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
Gopalan-Kriczky P; Hiruma S; Lotlikar PD
Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
[TBL] [Abstract][Full Text] [Related]
5. Modulation of aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci by pretreatment of rats with phenobarbital and buthionine sulfoximine.
Gopalan P; Tsuji K; Lehmann K; Kimura M; Shinozuka H; Sato K; Lotlikar PD
Carcinogenesis; 1993 Jul; 14(7):1469-70. PubMed ID: 8330366
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
Standeven AM; Wetterhahn KE
Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
Kera Y; Ohbora Y; Komura S
Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
[TBL] [Abstract][Full Text] [Related]
8. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
Sun JD; Ragsdale SS; Benson JM; Henderson RF
Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity after 3'-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice.
Tirmenstein MA; Nelson SD
Chem Res Toxicol; 1991; 4(2):214-7. PubMed ID: 1782350
[TBL] [Abstract][Full Text] [Related]
10. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
Kramer RA; Schuller HM; Smith AC; Boyd MR
J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683
[TBL] [Abstract][Full Text] [Related]
11. Changes in conjugative enzyme activity and acetaminophen metabolism in young and senescent male F-344 rats following prolonged exposure to buthionine sulfoximine.
Galinsky RE; Manning BW; Kimura RE; Franklin MR
Exp Gerontol; 1992; 27(2):221-32. PubMed ID: 1521595
[TBL] [Abstract][Full Text] [Related]
12. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
Ishikawa M; Takayanagi G; Sasaki K
Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
[TBL] [Abstract][Full Text] [Related]
13. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
Manning BW; Franklin MR
Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
[TBL] [Abstract][Full Text] [Related]
14. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Nakahori Y; Yamamoto K
Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
[TBL] [Abstract][Full Text] [Related]
15. Styrene-induced hepatotoxicity in mice depleted of glutathione.
Mizutani T; Irie Y; Nakanishi K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):361-74. PubMed ID: 7712112
[TBL] [Abstract][Full Text] [Related]
16. Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
Dahm LJ; Roth RA
Biochem Pharmacol; 1991 Aug; 42(6):1181-8. PubMed ID: 1679629
[TBL] [Abstract][Full Text] [Related]
17. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
Drew R; Miners JO
Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
[TBL] [Abstract][Full Text] [Related]
18. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
Campbell EB; Hayward ML; Griffith OW
Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
[TBL] [Abstract][Full Text] [Related]
19. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
Coursin DB; Cihla HP
Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
[TBL] [Abstract][Full Text] [Related]
20. The effect of depletion of nonprotein sulfhydryls by diethyl maleate plus buthionine sulfoximine on renal uptake of mercury in the rat.
Baggett JM; Berndt WO
Toxicol Appl Pharmacol; 1986 May; 83(3):556-62. PubMed ID: 3705075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
